new
decad
st
centuri
start
emerg
novel
coronaviru
known
caus
epidem
coronaviru
diseas
wuhan
china
third
highli
pathogen
transmiss
coronaviru
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
human
sourc
origin
transmiss
human
mechan
associ
pathogen
yet
clear
howev
resembl
sarscov
sever
bat
coronavirus
recent
confirm
genom
sequencingrel
studi
develop
therapeut
strategi
necessari
order
prevent
epidem
cure
infect
review
summar
current
inform
emerg
origin
divers
epidemiolog
three
pathogen
coronavirus
specif
focu
current
outbreak
wuhan
china
furthermor
discuss
clinic
featur
potenti
therapeut
option
may
effect
onset
fever
respiratori
symptom
occur
approxim
day
presumpt
exposur
diagnost
test
primarili
done
public
health
laboratori
delay
test
result
need
administr
oversight
test
nation
region
level
well
time
need
transport
specimen
high
volum
test
need
region
rapid
test
wide
avail
event
epidem
highlevel
test
facil
region
hospit
commerci
laboratori
need
addit
commerci
avail
test
undergon
regulatori
approv
sever
test
valid
public
health
author
includ
china
germani
thailand
japan
unit
state
technic
guidanc
feb
test
revers
transcriptas
pcr
rtpcr
test
use
primer
probe
design
detect
varieti
target
genom
although
design
valid
current
limit
inform
avail
relat
perform
test
sensit
specif
test
wide
known
might
detect
relat
coronavirus
sarscov
addit
util
differ
specimen
type
detect
virus
known
result
test
multipl
specimen
type
recommend
agenc
includ
cdc
avail
serolog
test
unclear
presum
test
develop
moreov
collect
submiss
sera
potenti
infect
patient
recommend
public
health
laboratori
cdc
issu
recommend
laboratori
safeti
test
specimen
patient
suspect
infect
guidelin
recommend
manipul
potenti
infecti
specimen
done
biosafeti
cabinet
potenti
splash
gener
droplet
aerosol
viral
isol
cultur
done
laboratori
test
chemistri
hematolog
laboratori
done
follow
routin
laboratori
precaut
recommend
work
current
promis
antivir
treatment
avail
howev
numer
compound
proven
effect
sarscov
merscov
test
wide
newli
emerg
remdesivir
chloroquin
found
highli
effect
vitro
control
infect
treatment
remdesivir
alon
combin
chloroquin
interferon
beta
found
effect
infect
strategi
caus
obviou
side
effect
yet
howev
investig
necessari
confirm
impact
remdesivir
coronavirus
share
key
genom
element
common
therapeut
target
like
greater
import
therapeut
agent
target
nucleosid
nucleotid
viral
nucleic
acid
enzymesprotein
involv
replic
transcript
coronavirus
promis
strategi
treat
coronaviru
diseas
tabl
surfac
spike
glycoprotein
import
potenti
target
antivir
agent
due
vital
role
interact
viru
cell
receptor
consist
two
subunit
aminotermin
receptor
bind
subunit
carboxytermin
membran
fusion
subunit
addit
activ
membran
fusion
viru
entri
requir
cleavag
junction
henc
subunittarget
monoclon
antibodi
subunittarget
fusion
inhibitor
may
effect
therapeut
agent
coronavirus
furin
serin
endoproteas
cleav
could
thu
suitabl
antivir
agent
helic
nucleocapsid
interact
protein
envelop
protein
membran
protein
form
assembl
virion
therefor
target
structur
gene
use
small
interf
rna
could
effect
therapeut
strategi
coronavirus
host
receptor
also
associ
viral
bananin
target
helicas
inhibit
unwind
activ
atpas
effect
broadspectrum
virus
evalu
aryl
diketoacid
adk
target
helicas
inhibit
unwind
effect
broad
rang
virus
includ
sarsmerscov
may
suitabl
choic
target
oligosaccharid
block
viral
bind
host
cell
effect
sarsmerscov
high
pathogen
virus
thu
might
use
hexamethylen
amilorid
target
viral
envelop
inhibit
ion
channel
activ
effect
differ
coronavirus
thu
one
suitabl
treatment
option
target
lipid
membran
caus
modif
phospholipid
effect
differ
virus
may
promis
agent
induc
immun
respons
recombin
interferon
found
effect
wide
rang
virus
suitabl
option
induc
immun
respons
recombin
interferon
found
effect
wide
rang
virus
may
promis
use
cyclosporin
alisporivir
inhibit
cyclophilin
affect
calcineurinnfat
pathway
inhibit
broadspectrum
virus
specif
coronavirus
thu
could
suitabl
option
treat
inhibit
kinas
signal
associ
pathway
block
viral
entri
entri
host
cell
thu
agent
target
receptor
also
inhibit
coronavirus
inhibitor
endosom
cystein
proteas
transmembran
proteas
serin
partial
block
viral
entri
cell
target
membranebound
rna
synthesi
coronavirus
inhibit
doublemembran
vesicl
format
thu
could
effect
broadspectrum
antivir
dsrnaactiv
caspas
oligomer
draco
select
induc
apoptosi
viruscontain
host
cell
provid
anoth
class
evalu
effect
howev
class
provid
promis
strategi
alon
block
viru
entri
disrupt
viral
nucleic
acid
contrast
thiopurin
compound
naphthalen
inhibitor
proteas
inhibitor
zinc
mercuri
conjug
target
proteas
plpro
papainlik
proteas
enzym
coronavirus
shown
block
pathogen
therefor
combin
therapi
antivir
agent
draco
may
enhanc
overal
impact
recoveri
patient
despit
higher
rate
infecti
coronavirus
thought
abil
suppress
counteract
respons
host
innat
interferon
respons
augment
util
interferon
induc
recombin
interferon
recombin
interferon
interferon
alpha
interferon
beta
test
sarscov
might
util
either
alon
combin
potenti
antivir
drug
includ
remdesivir
interferon
alpha
beta
inhibit
viral
replic
use
interferon
induc
combin
effect
antivir
agent
worth
evalu
possibl
synergist
effect
addit
calcineurin
inhibitor
cyclosporin
combin
antibiot
tradit
chines
medicin
could
also
evalu
activ
effect
vaccin
import
prevent
control
sporad
viral
attack
emerg
virusmedi
epidem
recent
outbreak
caus
although
sarscov
fulli
control
merscov
prevent
caus
high
mortal
rate
newli
emerg
spread
effici
signific
increas
number
case
fatal
pass
day
vaccin
requir
prevent
caus
liveattenu
vaccin
design
sar
may
evalu
infect
patient
addit
rhesu
defensin
protein
cage
nanoparticl
innat
immunomodul
high
antisarscov
effici
base
high
similar
phylogenet
related
sarscov
protein
cage
nanoparticl
design
sarscov
evalu
meanwhil
follow
similar
strategi
util
sarscov
novel
protein
cage
nanoparticl
specifi
novel
coronaviru
design
emerg
basi
given
urgenc
current
scenario
outbreak
vaccin
strategi
base
viral
vector
recombin
protein
virallik
particl
develop
develop
sar
andor
mer
could
modifi
util
despit
current
progress
work
need
develop
safe
effect
vaccin
avail
individu
high
risk
endem
control
ongo
risk
futur
epidem
interest
featur
plasma
recov
patient
presenc
activ
antibodi
transfer
plasma
peopl
recov
infect
individu
might
enhanc
immun
monoclon
antibodi
could
inhibit
viruscel
receptor
bind
interrupt
viruscel
fusion
develop
combin
two
monoclon
antibodi
may
suitabl
quicker
recoveri
patient
lastli
antivir
peptid
target
differ
region
peptid
effect
viral
infect
also
consid
although
strategi
sarscov
develop
includ
receptorbind
domain
rbd
base
vaccin
requir
evalu
given
import
current
outbreak
wuhan
studi
need
deepen
understand
replic
pathogenesi
biolog
properti
use
revers
genet
relat
molecular
techniqu
investig
help
control
prevent
pneumonia
diseas
novel
emerg
diseas
futur
sarscov
merscov
report
origin
recombin
within
bat
virus
introduct
guangdong
provinc
civet
middl
east
camel
respect
sarscov
strain
becam
epidem
sever
independ
spillov
human
outbreak
guangdong
china
similarli
merscov
becam
epidem
seri
human
infect
middl
eastern
countri
virus
transfer
sever
countri
beyond
countri
origin
howev
unlik
continu
propag
merscov
epidem
sarscov
outbreak
success
control
base
origin
coronavirus
like
origin
bat
introduc
wuhan
china
unknown
intermedi
effect
clinic
treatment
prevent
strategi
avail
use
human
coronavirus
test
drug
coronavirus
requir
suitabl
anim
model
prior
use
human
current
establish
model
promis
studi
pathogenesi
treatment
highli
pathogen
coronavirus
instanc
nonhuman
primat
unabl
reproduc
characterist
sever
human
diseas
mortal
observ
howev
small
anim
develop
clinic
symptom
diseas
transgen
mice
express
human
mouseadapt
sarscov
strain
one
suitabl
model
addit
transgen
mice
express
human
suitabl
small
anim
model
mer
like
anim
model
sarscov
transgen
anim
model
may
also
standard
develop
clinic
drug
coronavirus
challeng
repeat
emerg
novel
coronavirus
divers
featur
thu
requir
specif
drug
newli
emerg
viru
moreov
limit
number
anim
model
avail
use
highli
demand
biosafeti
level
lab
perspect
current
outbreak
design
effect
therapeut
yet
anoth
challeng
scientist
although
larg
number
antivir
treatment
option
sar
mer
report
potent
vitro
activ
limit
number
may
potenti
clinic
set
move
forward
treatment
option
avail
could
util
clinic
ongo
epidem
broadspectrum
antivir
drug
may
effect
opportun
test
current
scenario
pneumonia
wuhan
china
broadrang
combin
therapi
includ
lopinavir
interferon
antivir
peptid
also
evalu
examin
agent
shown
signific
effect
mer
nonhuman
primat
design
develop
novel
broadspectrum
antivir
drug
potenti
target
coronavirus
may
prove
best
treatment
option
reemerg
circul
coronavirus
